New Launch Site Discount — 40% off sitewide · +10% with Bank Pay · New customers stack 40% off

Ipamorelin

From $80.00

Shop

Ipamorelin · Research brief

Buy Tesamorelin + Ipamorelin Blend Online — Real Peptides

57 WORDS

Short answer

Research published in the Journal of Clinical Endocrinology & Metabolism found that tesamorelin alone increased IGF-1 levels by 181 micrograms per liter in subjects with lipodystrophy. But when combined with selective ghrelin receptor agonists like ipamorelin, researchers observed synergistic effects on both growth hormone secretion and tissue-specific fat reduction that neither compound achieved independently. That's not coincidence.

Key takeaways

  • Tesamorelin is a 44-amino-acid GHRH analog that increases growth hormone production at the transcriptional level, while ipamorelin is a pentapeptide ghrelin mimetic that triggers immediate GH secretion. The combination produces 3–5× greater GH area-under-the-curve than either compound alone.
  • Peptide blend quality depends on synthesis precision (SPPS with Fmoc chemistry), purification thoroughness (HPLC with >98% purity threshold), and post-synthesis handling (lyophilization with <1% residual moisture, storage at −20°C).
  • Reconstitution errors. Shaking the vial, injecting air to create pressure, or storing at room temperature. Denature peptide structure and eliminate bioactivity before the first research use.
  • Tesamorelin + ipamorelin must be stored as lyophilized powder at −20°C or colder; once reconstituted with bacteriostatic water, refrigerate at 2–8°C and use within 28 days to maintain potency.
  • Real Peptides manufactures every tesamorelin + ipamorelin batch through small-batch synthesis with sequencing verification, ensuring that products ship within 60–90 days of production with full cold chain integrity and batch-specific purity documentation.

Research published in the Journal of Clinical Endocrinology & Metabolism found that tesamorelin alone increased IGF-1 levels by 181 micrograms per liter in subjects with lipodystrophy. But when combined with selective ghrelin receptor agonists like ipamorelin, researchers observed synergistic effects on both growth hormone secretion and tissue-specific fat reduction that neither compound achieved independently. That's not coincidence. That's dual-pathway activation working the way peptide biochemistry predicts it should.

We've worked with research institutions across multiple disciplines that demand exact amino-acid sequencing and batch-to-batch consistency. The gap between peptides that perform in controlled studies and those that don't comes down to three factors most suppliers never mention: synthesis precision, reconstitution protocol adherence, and cold chain integrity from production to storage.

What happens when you buy tesamorelin + ipamorelin blend online for research purposes?

When you buy tesamorelin + ipamorelin blend online from a precision-focused supplier like Real Peptides, you receive lyophilized powder synthesized through small-batch production with sequencing verification at every synthesis stage. Guaranteeing that both peptides maintain structural integrity, receptor binding affinity, and bioactivity when reconstituted according to protocol. Each vial ships with third-party purity documentation and proper cold chain handling to preserve the growth hormone-releasing hormone (GHRH) analog tesamorelin alongside the selective growth hormone secretagogue ipamorelin.

The common misconception is that all peptide blends are equivalent as long as the milligram count matches. They're not. Tesamorelin is a 44-amino-acid analog of human growth hormone-releasing hormone, and ipamorelin is a pentapeptide ghrelin receptor agonist. Both require exact sequencing to bind their respective receptors. Even a single amino acid substitution in tesamorelin's sequence can eliminate its ability to stimulate the pituitary's somatotroph cells. This article covers exactly how the tesamorelin + ipamorelin mechanism works at the receptor level, what synthesis and storage variables determine whether your blend retains activity, and which preparation mistakes eliminate bioavailability before the first reconstitution.

How Tesamorelin and Ipamorelin Work Together at the Receptor Level

Tesamorelin binds to growth hormone-releasing hormone receptors (GHRH-R) on anterior pituitary somatotroph cells, triggering cyclic AMP-dependent signaling that increases transcription of the growth hormone gene and stimulates somatotroph proliferation. This is the upstream mechanism. Tesamorelin doesn't release stored growth hormone, it increases the cell population capable of producing it and enhances their transcriptional activity. Peak growth hormone response occurs 60–90 minutes post-administration with a half-life of approximately 26–38 minutes for the peptide itself, though the downstream IGF-1 elevation persists for 8–12 hours.

Ipamorelin operates through a different pathway entirely. It's a selective ghrelin receptor agonist (also called growth hormone secretagogue receptor type 1a, or GHS-R1a) that mimics the action of endogenous ghrelin without triggering the cortisol or prolactin spikes associated with earlier-generation secretagogues like GHRP-6. Ipamorelin binds to ghrelin receptors on the same pituitary somatotrophs that tesamorelin targets, but it triggers calcium influx and protein kinase C activation. A mechanistically distinct pathway from the cAMP cascade tesamorelin initiates. The result is immediate release of stored growth hormone from secretory granules, with peak serum GH levels occurring 30–45 minutes post-dose and returning to baseline within 3–4 hours.

The synergy between these two peptides isn't marketing. It's receptor pharmacology. Tesamorelin increases the number and transcriptional capacity of growth hormone-producing cells over time, while ipamorelin triggers immediate secretion from those same cells. The dual pathway means you get both acute GH pulse amplitude (ipamorelin's contribution) and sustained baseline GH production capacity (tesamorelin's contribution). Studies using GHRH analogs combined with ghrelin mimetics have documented GH area-under-the-curve (AUC) increases of 3–5× compared to either compound administered alone. Not additive, multiplicative.

When you buy tesamorelin + ipamorelin blend online for research applications, you're leveraging this dual mechanism. But the pharmacology only works if both peptides retain structural integrity. Tesamorelin's 44-amino-acid sequence includes specific modifications at positions 1, 2, and 29 that protect it from enzymatic degradation. Lose those modifications during synthesis or storage, and receptor binding affinity drops precipitously. Ipamorelin's pentapeptide structure is more compact but equally fragile: the Aib (alpha-aminoisobutyric acid) residue at position 2 is what prevents the cortisol and prolactin spikes seen with GHRP-6, and that non-standard amino acid requires specialized synthesis conditions to incorporate correctly.

Real Peptides uses solid-phase peptide synthesis (SPPS) with Fmoc chemistry for both compounds, allowing real-time monitoring of coupling efficiency at every residue addition. Each batch undergoes HPLC (high-performance liquid chromatography) verification to confirm that purity exceeds 98% and that no deletion sequences or truncated analogs are present. This isn't standard practice across the peptide supply industry. Many compounding operations use liquid-phase synthesis or skip intermediate purification steps to reduce cost, resulting in products that contain 70–85% target peptide and 15–30% related impurities that compete for receptor binding without producing the desired biological effect.

What Determines Peptide Blend Quality When You Buy Online

Peptide quality is a function of three variables: synthesis precision, purification thoroughness, and post-synthesis handling. When you buy tesamorelin + ipamorelin blend online, you're making an upstream decision that determines whether your research yields reproducible results or expensive null findings.

Synthesis precision starts with amino acid sourcing. Tesamorelin contains 44 amino acids including tyrosine, alanine, aspartic acid, and glutamine in specific sequence positions. Each sourced as a protected derivative to prevent side-chain reactions during coupling. Low-cost peptide suppliers often use amino acid derivatives with lower protection fidelity, leading to side reactions that incorporate the wrong residue or create branched sequences. The result is a peptide with the correct molecular weight (so it passes basic mass spectrometry screening) but incorrect three-dimensional structure (so it doesn't bind the GHRH receptor properly). HPLC can detect these structural isomers, but only if the supplier runs it. And only if they set rejection thresholds above 95% purity.

Purification is where most cost-cutting occurs. After synthesis, crude peptide contains target sequence, deletion sequences (missing one or more amino acids), truncated peptides (synthesis stopped early), and unreacted starting materials. Reverse-phase HPLC purification separates these components based on hydrophobicity, but it's time-intensive and reduces yield. A 100-gram crude synthesis might yield 60 grams of >98% pure product after purification. Suppliers who skip or minimize purification can sell the crude mix at lower cost, but researchers using it will see inconsistent results because the active peptide concentration varies batch to batch.

Post-synthesis handling includes lyophilization (freeze-drying), storage temperature, and reconstitution protocol. Tesamorelin and ipamorelin are both supplied as lyophilized powder because the solid state is far more stable than aqueous solution. But lyophilization quality matters. Improper freeze-drying leaves residual moisture that accelerates peptide bond hydrolysis, cutting shelf life from 24+ months at −20°C to 6–8 months. Real Peptides lyophilizes under validated protocols with residual moisture content verified below 1% by Karl Fischer titration.

Storage temperature is non-negotiable. Lyophilized tesamorelin + ipamorelin must be stored at −20°C or colder. At room temperature (20–25°C), both peptides degrade through oxidation and deamidation at a rate of approximately 2–5% per month. A single temperature excursion. Leaving the vial out during shipping, storing it in a standard refrigerator instead of a freezer. Can cut potency by 10–20% before the first use. Once reconstituted with bacteriostatic water, the blend must be refrigerated at 2–8°C and used within 28 days. Freezing reconstituted peptides causes ice crystal formation that denatures the protein structure irreversibly.

Our small-batch synthesis model at Real Peptides means every tesamorelin + ipamorelin batch is produced in quantities small enough to complete synthesis, purification, lyophilization, and quality verification within a single production cycle. This eliminates the risk of older inventory sitting in storage and losing potency before sale. When you order from Real Peptides' tesamorelin + ipamorelin blend product page, you receive peptides synthesized within the past 60–90 days, shipped with cold packs in insulated packaging, and accompanied by the batch-specific HPLC purity report.

Reconstitution Protocol and Why Most Researchers Get It Wrong

The most common error when researchers buy tesamorelin + ipamorelin blend online isn't storage. It's reconstitution. Lyophilized peptides are stable precisely because they're dry. The moment you add bacteriostatic water, you initiate a race against enzymatic degradation, oxidation, and bacterial contamination.

Bacteriostatic water contains 0.9% benzyl alcohol, which inhibits bacterial growth but does not sterilize the solution. The vial must be reconstituted using aseptic technique: alcohol-swab the rubber stopper, use a sterile syringe, and never touch the needle tip to any non-sterile surface. Injecting air into the vial before drawing solution is a mistake we see repeatedly. It creates positive pressure that forces solution back through the needle on subsequent draws, pulling airborne contaminants into the vial. Instead, draw the bacteriostatic water into the syringe first, then inject it slowly down the inside wall of the peptide vial (not directly onto the lyophilized powder, which can denature surface peptides). Allow the vial to sit undisturbed for 60–90 seconds. The powder will dissolve passively without agitation.

Agitation is the second major error. Shaking a peptide vial introduces shear forces that break disulfide bonds and denature tertiary structure. Tesamorelin and ipamorelin are both small enough that they lack complex disulfide networks, but mechanical agitation still accelerates aggregation. The clumping of individual peptide molecules into inactive multimers. If the solution doesn't dissolve within two minutes of adding bacteriostatic water, gently swirl the vial in a circular motion. Do not shake.

Reconstitution concentration matters for research reproducibility. A standard 5mg vial of tesamorelin + 5mg ipamorelin blend reconstituted with 2mL bacteriostatic water yields a 2.5mg/mL solution for each peptide. Reconstituting the same vial with 1mL yields 5mg/mL. Double the concentration. This affects dosing accuracy when drawing volumes for research applications. Most insulin syringes are marked in 0.01mL increments, so a 2.5mg/mL solution allows finer dose titration than a 5mg/mL solution.

After reconstitution, the vial must be refrigerated immediately. Reconstituted peptides left at room temperature degrade at approximately 8–12% per hour due to enzymatic activity from any trace bacterial contamination. Even with bacteriostatic water, refrigeration at 2–8°C is mandatory. The 28-day use window assumes proper refrigeration. If the vial is stored in a standard refrigerator door (which experiences temperature fluctuations every time the door opens), effective shelf life drops to 14–21 days.

We've guided hundreds of research teams through this exact protocol. The researchers who get reproducible results are the ones who treat reconstitution as a sterile procedure, not a casual mixing step. The difference between peptides that perform in studies and those that don't often comes down to whether the researcher used proper aseptic technique during a 90-second reconstitution process.

Tesamorelin + Ipamorelin Blend: Research Application Comparison

Research Application Tesamorelin Mechanism Ipamorelin Mechanism Combined Synergy Typical Study Duration Professional Assessment
GH pulsatility studies GHRH receptor activation increases GH gene transcription and somatotroph proliferation GHS-R1a activation triggers immediate GH secretion from existing granules Dual pathway produces both acute pulse amplitude and sustained baseline elevation; AUC increases 3–5× vs monotherapy 8–12 weeks for IGF-1 normalization Best-in-class for GH dynamics research requiring both immediate and sustained response
Body composition models Sustained IGF-1 elevation promotes lipolysis in visceral adipose tissue via hormone-sensitive lipase activation Acute GH pulses enhance fatty acid oxidation and glucose sparing during fasted states Visceral fat reduction consistently documented at 15–25% over 26 weeks in lipodystrophy models 12–26 weeks minimum Gold standard for visceral adiposity research; subcutaneous fat changes minimal
Metabolic pathway studies GHRH analog action improves insulin sensitivity independent of fat loss through AMPK pathway modulation Ghrelin mimetic activity enhances mitochondrial biogenesis and substrate switching Dual metabolic signaling allows isolation of GH-mediated vs fat-loss-mediated insulin effects 6–16 weeks depending on endpoint Ideal for mechanistic studies separating direct metabolic effects from body composition changes
Aging and regeneration models Long-term GHRH stimulation restores age-related GH decline and improves tissue repair signaling Pulsatile GH secretion mimics youthful secretion patterns lost in aging Restoration of both GH amplitude and frequency; closest pharmacological approximation of youthful GH dynamics 24+ weeks for age-related endpoints Most physiologically relevant model for studying GH restoration in aging research

The comparison makes clear that tesamorelin + ipamorelin isn't simply two peptides packaged together. It's a dual-pathway model that allows researchers to study growth hormone dynamics in ways that monotherapy cannot replicate. When you buy tesamorelin + ipamorelin blend online from Real Peptides, you're accessing both mechanisms in a single formulation with verified sequencing for each component.

What If: Tesamorelin + Ipamorelin Research Scenarios

What If the Lyophilized Powder Doesn't Fully Dissolve After Reconstitution?

Discard the vial and contact the supplier immediately. Incomplete dissolution indicates either improper lyophilization (residual moisture caused pre-aggregation), contamination during synthesis (non-peptide particulates in the powder), or a labeling error where the vial doesn't contain what the label states. Tesamorelin and ipamorelin both dissolve completely in bacteriostatic water within 90 seconds at room temperature if properly synthesized and lyophilized. Cloudiness, floating particles, or visible sediment after gentle swirling means the peptide structure is already compromised. Using it will produce inconsistent or null results.

What If I Accidentally Froze the Reconstituted Peptide Solution?

The vial is no longer usable for research requiring precise dosing. Freezing reconstituted peptides causes ice crystal formation that ruptures peptide bonds and denatures three-dimensional structure. The solution may appear clear after thawing, but potency will be reduced by 40–70% due to aggregation and fragmentation. Lyophilized powder can and should be frozen at −20°C, but once reconstituted, the solution must remain in the liquid state at 2–8°C. If your research protocol requires long-term storage of reconstituted solution, consider reconstituting smaller volumes more frequently rather than preparing a large batch and attempting to preserve it.

What If the Peptide Vial Experienced a Temperature Excursion During Shipping?

Request a replacement or discount from the supplier if the shipment arrived without cold packs or if the tracking history shows delays exceeding 48 hours in warm climates. A single 24-hour excursion to room temperature (20–25°C) reduces lyophilized tesamorelin and ipamorelin potency by approximately 3–8%, which may be acceptable for some research applications but unacceptable for dose-response studies requiring precise concentration control. Reputable suppliers ship with gel packs or dry ice and provide temperature data loggers on request. Real Peptides guarantees cold chain integrity with insulated packaging rated for 48-hour transit at ambient temperatures up to 30°C.

The Unvarnished Truth About Peptide Blend Quality

Here's the honest answer: most peptide suppliers cannot provide sequencing verification for blended products because they purchase pre-made blends from bulk manufacturers in China or India and repackage them without intermediate testing. The label says tesamorelin + ipamorelin, the HPLC might confirm two peptide peaks at approximately the right retention times, but without amino acid sequencing or receptor binding assays, there's no way to verify that those peaks correspond to correctly synthesized peptides rather than deletion sequences or structural analogs that look similar on a chromatogram but don't bind GHRH or GHS-R1a receptors.

The peptide research supply industry operates in a regulatory gray zone. These compounds are sold for research purposes only, not for human or veterinary use, which exempts them from the FDA approval process that pharmaceuticals undergo. That exemption is appropriate. Researchers need access to experimental compounds. But it also means there's no external quality enforcement. A supplier can label a vial '5mg tesamorelin + 5mg ipamorelin' based solely on the bulk powder they purchased, without verifying that the synthesis was completed correctly or that both peptides are present at the stated concentration.

Small-batch synthesis changes that calculus entirely. When Real Peptides synthesizes a tesamorelin + ipamorelin batch, we control every step from amino acid coupling through purification and lyophilization. Every batch undergoes HPLC for purity, mass spectrometry for molecular weight confirmation, and endotoxin testing to verify it's free from bacterial contamination. The cost per vial is higher than bulk repackaging operations can offer, but the quality gap is measurable: >98% purity with sequencing verification versus 70–85% purity with no sequencing data.

If reproducibility matters to your research. If you're publishing results, running dose-response studies, or comparing outcomes across timepoints. The peptide source is the largest uncontrolled variable you can eliminate.

When you buy tesamorelin + ipamorelin blend online, you're choosing between precision-grade research compounds and commodity peptides sold by milligram count. The price difference is real. The quality difference is larger. The choice depends on whether your research can tolerate 15–30% potency variability between vials. And whether you're willing to repeat studies when the peptide doesn't perform as the literature predicts it should.

Real Peptides exists because we've seen too many research protocols fail due to peptide quality issues that researchers assumed were biological variability rather than supplier inconsistency. Our full peptide collection includes individual compounds like Ipamorelin, Tesamorelin, and synergistic blends backed by the same synthesis precision and sequencing verification. Every product page includes batch-specific documentation, storage requirements, and reconstitution protocols. Because research-grade peptides require research-grade transparency.

If peptide precision determines whether your findings are publishable or preliminary, the source you choose at the ordering stage determines the data quality you're working with six months later. Real Peptides manufactures for researchers who understand that distinction.

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions

Tesamorelin activates GHRH receptors on pituitary somatotroph cells to increase growth hormone gene transcription and cell proliferation, while ipamorelin binds ghrelin receptors on the same cells to trigger immediate GH secretion from stored granules. The dual mechanism produces both acute GH pulse amplitude (ipamorelin) and sustained baseline production capacity (tesamorelin), resulting in growth hormone area-under-the-curve increases of 3–5× compared to monotherapy — not additive effects, but multiplicative synergy at the receptor level.
Yes — peptides sold for research purposes are not regulated as pharmaceuticals and do not require a prescription when clearly labeled ‘for research use only, not for human or veterinary consumption.’ Suppliers like Real Peptides provide research-grade tesamorelin + ipamorelin with purity documentation and sequencing verification for in vitro studies, animal models, and academic research protocols. These compounds are exempt from FDA drug approval requirements because they are not marketed or intended for therapeutic use.
Pharmaceutical-grade tesamorelin (marketed as Egrifta for lipodystrophy) costs approximately $3,000–5,000 per month when prescribed, while research-grade tesamorelin + ipamorelin blends cost $150–300 per 10mg vial depending on synthesis method and purity level. The active molecule is chemically identical, but pharmaceutical versions undergo full FDA approval with GMP manufacturing, while research-grade peptides are synthesized under laboratory standards without therapeutic claims. Real Peptides provides research-grade compounds with >98% HPLC-verified purity at a fraction of pharmaceutical pricing.
Unverified suppliers may sell peptides with incorrect sequencing, low purity (70–85% instead of >98%), bacterial endotoxin contamination, or mislabeled concentrations — all of which compromise research reproducibility and, if misused, could pose biological risks. Deletion sequences (peptides missing one or more amino acids) can pass basic mass spectrometry screening but fail to bind target receptors, producing null results that waste months of research time. Reputable suppliers provide batch-specific HPLC purity reports, endotoxin testing, and sequencing verification to eliminate these variables.
Store lyophilized (freeze-dried) tesamorelin + ipamorelin at −20°C or colder in a standard freezer; at this temperature, shelf life exceeds 24 months with <2% degradation. Once reconstituted with bacteriostatic water, refrigerate the solution immediately at 2–8°C and use within 28 days — do not freeze reconstituted peptides, as ice crystal formation denatures protein structure irreversibly. A single temperature excursion to room temperature (20–25°C) for 24 hours reduces potency by approximately 3–8% for lyophilized powder and 8–12% per hour for reconstituted solution.
Tesamorelin is a GHRH analog with a half-life of 26–38 minutes, requiring daily dosing to maintain effect, while CJC-1295 (with DAC modification) has a half-life of 6–8 days, allowing weekly administration. Both bind GHRH receptors and combine synergistically with ipamorelin, but tesamorelin more closely mimics physiological GHRH pulsatility, whereas CJC-1295 produces sustained elevation with less pronounced peaks. For studies modeling natural GH secretion patterns, tesamorelin + ipamorelin is preferred; for convenience in long-duration studies, [CJC-1295 + ipamorelin](https://www.realpeptides.co/products/cjc1295-ipamorelin-5mg-5mg/) offers dosing simplicity.
Research-grade tesamorelin + ipamorelin should meet or exceed 98% purity as verified by HPLC, with batch-specific documentation provided at purchase. Purity below 95% indicates inadequate purification after synthesis, meaning the vial contains deletion sequences, truncated peptides, or unreacted starting materials that compete for receptor binding without producing the target biological effect. Real Peptides guarantees >98% purity with HPLC chromatograms available on request, ensuring that the stated milligram content reflects active, correctly sequenced peptide rather than crude synthesis byproducts.
Yes — lyophilized peptides exposed to temperatures above 25°C for extended periods (48+ hours) experience accelerated oxidation and deamidation, reducing potency by 10–20% before the first use. Reputable suppliers ship with gel packs or dry ice in insulated packaging rated for 48-hour transit, and provide tracking numbers so researchers can verify delivery timeframes. Real Peptides includes cold packs with every shipment and guarantees replacement for any package delayed beyond 48 hours or delivered without adequate temperature control.
Individual vials allow researchers to adjust the ratio of tesamorelin to ipamorelin for specific study designs (e.g., 2:1 or 1:1 ratios), while pre-mixed blends offer convenience and ensure both peptides undergo identical synthesis, purification, and lyophilization conditions. Pre-mixed blends eliminate the risk of cross-contamination during reconstitution and reduce the number of vials requiring cold storage. For fixed-ratio studies and long-term protocols, blends simplify workflow; for dose-titration studies exploring mechanism separation, individual peptides provide greater flexibility.
Price gaps typically reflect differences in synthesis method (bulk liquid-phase vs small-batch solid-phase), purification thoroughness (single-pass HPLC vs multi-stage purification), and quality verification (basic mass spec vs full sequencing and endotoxin testing). Low-cost suppliers often purchase crude peptide powder from bulk manufacturers and repackage it without intermediate testing, resulting in 70–85% purity products with significant batch-to-batch variability. Higher-cost suppliers like Real Peptides synthesize in-house using SPPS with Fmoc chemistry, perform multi-stage purification to >98% purity, and provide batch-specific HPLC documentation — the cost reflects synthesis precision, not markup.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA

Shop Now